Company Filing History:
Years Active: 2004
Title: Amina Faham: Innovator in Orodispersible Tablet Technology
Introduction
Amina Faham is a notable inventor based in Montréal, Canada. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of orodispersible tablets. Her innovative work aims to improve the delivery and effectiveness of medications for patients.
Latest Patents
Amina Faham holds a patent for orodispersible tablets containing fexofenadine. This invention focuses on tablets that can disintegrate in the buccal cavity upon contact with saliva, forming an easy-to-swallow suspension in less than 60 seconds, preferably in less than 40 seconds. The tablets contain fexofenadine in the form of coated granules, along with a mixture of excipients that include at least one disintegrating agent, a soluble diluent agent, a lubricant, and optional ingredients such as a swelling agent, a permeabilizing agent, sweeteners, flavoring agents, and colors. This invention is particularly useful in the treatment of seasonal allergic rhinitis.
Career Highlights
Amina Faham is currently associated with Ethypharm, Inc., where she continues to advance her research and development efforts. Her work has garnered attention for its potential to enhance patient compliance and improve therapeutic outcomes.
Collaborations
Amina collaborates with talented professionals in her field, including Dominique Marechal and Philippe Chenevier. These partnerships contribute to the innovative environment at Ethypharm, Inc., fostering the development of cutting-edge pharmaceutical solutions.
Conclusion
Amina Faham's contributions to the field of orodispersible tablets represent a significant advancement in pharmaceutical technology. Her innovative approach not only addresses patient needs but also showcases the importance of collaboration in driving progress in the industry.